These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. MeIQx-DNA adduct formation in rodent and human tissues at low doses. Turteltaub KW, Mauthe RJ, Dingley KH, Vogel JS, Frantz CE, Garner RC, Shen N. Mutat Res; 1997 May 12; 376(1-2):243-52. PubMed ID: 9202761 [Abstract] [Full Text] [Related]
4. Cytochrome P450-mediated metabolism and DNA binding of 2-amino-1,7-dimethylimidazo[4,5-g]quinoxaline and its carcinogenic isomer 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in mice. Turesky RJ, Bessette EE, Dunbar D, Liberman RG, Skipper PL. Chem Res Toxicol; 2012 Feb 20; 25(2):410-21. PubMed ID: 22118226 [Abstract] [Full Text] [Related]
5. Analysis and quantification of DNA adducts of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in liver of rats by liquid chromatography/electrospray tandem mass spectrometry. Paehler A, Richoz J, Soglia J, Vouros P, Turesky RJ. Chem Res Toxicol; 2002 Apr 20; 15(4):551-61. PubMed ID: 11952342 [Abstract] [Full Text] [Related]
6. Effect of N-acetyltransferase 2 polymorphism on tumor target tissue DNA adduct levels in rapid and slow acetylator congenic rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline. Metry KJ, Neale JR, Bendaly J, Smith NB, Pierce WM, Hein DW. Drug Metab Dispos; 2009 Nov 20; 37(11):2123-6. PubMed ID: 19666988 [Abstract] [Full Text] [Related]
7. Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo. Davis CD, Schut HA, Adamson RH, Thorgeirsson UP, Thorgeirsson SS, Snyderwine EG. Carcinogenesis; 1993 Jan 20; 14(1):61-5. PubMed ID: 8425272 [Abstract] [Full Text] [Related]
8. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice. Ryu DY, Pratt VS, Davis CD, Schut HA, Snyderwine EG. Cancer Res; 1999 Jun 01; 59(11):2587-92. PubMed ID: 10363978 [Abstract] [Full Text] [Related]
9. Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low dose. Mauthe RJ, Dingley KH, Leveson SH, Freeman SP, Turesky RJ, Garner RC, Turteltaub KW. Int J Cancer; 1999 Feb 09; 80(4):539-45. PubMed ID: 9935154 [Abstract] [Full Text] [Related]
10. Induction of DNA-adducts and increase of 8-hydroxy-2-deoxyguanosine, but no development of preneoplastic lesions in offspring liver with transplacental and trans-breast milk exposure to 2-amino-3,8-dimethylimidazo [4,5-f ]quinoxaline (MeIQx) in rats. Ichihara T, Wanibuchi H, Totsuka Y, Morimura K, Wei M, Nakae D, Fukushima S. Cancer Sci; 2004 Dec 09; 95(12):943-8. PubMed ID: 15596042 [Abstract] [Full Text] [Related]
11. Evidence of a threshold-effect for 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline liver carcinogenicity in F344/DuCrj rats. Murai T, Mori S, Kang JS, Morimura K, Wanibuchi H, Totsuka Y, Fukushima S. Toxicol Pathol; 2008 Apr 09; 36(3):472-7. PubMed ID: 18413788 [Abstract] [Full Text] [Related]
12. Excretion of food-derived heterocyclic amine carcinogens into breast milk of lactating rats and formation of DNA adducts in the newborn. Ghoshal A, Snyderwine EG. Carcinogenesis; 1993 Nov 09; 14(11):2199-203. PubMed ID: 8242844 [Abstract] [Full Text] [Related]
17. Formation and removal of DNA adducts in the liver of rats chronically fed the food-borne carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Hirose M, Wakabayashi K, Ochiai M, Kushida H, Sato H, Sugimura T, Nagao M. Jpn J Cancer Res; 1995 Jun 09; 86(6):516-22. PubMed ID: 7622414 [Abstract] [Full Text] [Related]